Breast Cancer Trend Analysis Using Stochastic Stimulati*
Breast Cancer Trend Analysis Using Stochastic Stimulati*
批准号:
7683773
负责人:
SYLVIA KATINA PLEVRITIS
金额:
$7.71万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-01 至 2011-08-31
关键词:
AddressAdoptedAdvocateAgeAgreementAwardBRCA1 geneBRCA2 geneBreastCancer ControlCancer Intervention and Surveillance Modeling NetworkCollaborationsDataDetectionDiseaseDisease ProgressionDocumentationEarly DiagnosisFamily history ofFemaleFutureGeneral PopulationGenetic Predisposition to DiseaseGenetic RiskGoalsHealthy People 2010IncidenceInterventionKnowledgeMagnetic Resonance ImagingMalignant NeoplasmsMammographyMedicalModalityModelingModificationMutationNatural HistoryNoninfiltrating Intraductal CarcinomaPerformancePhasePilot ProjectsPolicy MakerPopulationProtocols documentationRecurrenceRelative (related person)ResearchRiskRunningScreening procedureSimulateSource CodeSpecific qualifier valueSurrogate MarkersTechnologyTranslatingTreatment ProtocolsUnited StatesWorkattributable mortalitybasechemotherapyhigh riskinnovationmalignant breast neoplasmmembermodels and simulationmortalitynetwork modelsprogramstreatment trialtrendweb interface
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The main goal of our proposed research is to quantify the impact of screeningand treatment interventionson breast
cancer incidenceand mortality trends in the United States through a collaborative research agreement with the NCIs
Cancer Intervention and Surveillance Modeling Network (CISNET). Under our original CISNET award, we quantified
the relativecontributionsof screening mammography and multiagent chemotherapy to the recent decline in breast
cancer mortality. In this application, we are proposing to extend our analysis of the current breast cancer trends to
include the impact of screen-detected DCIS. We will also identify the component of current trends in breast cancer
incidence and mortality attributableto the subpopulation at high genetic risk for developingthe disease. In additionto
studying the current trends more closely, we will extend the use of our model to the study of future trends. Through a
CISNET/DHHS supplemental award, we have already performed a pilot study on the use of our model in determining
whether or not the Healthy People 2010 goals in breast cancer mortalitycould be achieved. This project revealed the
need to enhance our existing CISNET model so that it could take as inputs intermediate endpointsfrom screening and
treatment trials. More often than not the performance of medical innovations are being evaluated on short term
endpoints or surrogate markers. New treatment protocols are now being broadly adopted on the basis of lowered
recurrence rates, with little knowledge of their impact on survival. New screening technologies are being advocated on
the basis of increased detection rates, with little knowledgeof their impact on survival. We want to extrapolate the
intermediate endpoints of breast cancer trials in screening and treatment to long term survival endpoints and then
translate these findings to the population level. We will focus a part of our efforts on the study of new screening
technologies in the high risk population in order to better understand how these interventions can be translated to the
general population.We will make our CISNET model availablefor broader publicconsumption and welcome pressing
questions from policy makers during the course of our study.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1007/s10552-011-9866-9
发表时间:
2012-01
期刊:
CANCER CAUSES & CONTROL
影响因子:
2.3
作者:
[Lin, Ray S., Plevritis, Sylvia K.]
通讯作者:
Plevritis, Sylvia K.
DOI:
10.1093/jncimonographs/lgj012
发表时间:
2006-01-01
期刊:
Journal of the National Cancer Institute. Monographs
影响因子:
--
作者:
[Plevritis, Sylvia K, Sigal, Bronislava M, Glynn, Peter]
通讯作者:
Glynn, Peter
DOI:
10.1158/1055-9965.epi-12-0149
发表时间:
2012-07
期刊:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子:
--
作者:
[Sigal BM, Munoz DF, Kurian AW, Plevritis SK]
通讯作者:
Plevritis SK
DOI:
10.1158/0008-5472.can-13-0759
发表时间:
2014-01-15
期刊:
Cancer research
影响因子:
11.2
作者:
[Gallaher J, Babu A, Plevritis S, Anderson ARA]
通讯作者:
Anderson ARA
Feasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers.
在线工具的可行性评估,以指导BRCA1/2突变载体的决策。
DOI:
10.1007/s10689-012-9577-8
发表时间:
2013-03
期刊:
Familial cancer
影响因子:
2.2
作者:
[Schackmann EA, Munoz DF, Mills MA, Plevritis SK, Kurian AW]
通讯作者:
Kurian AW
Project 2 Human Tumor Analysis
-
批准号:10729467
-
项目类别:
-
资助金额:$52.27万
-
财政年份:2023
-
负责人:SYLVIA KATINA PLEVRITIS
-
依托单位:
Administrative Core
-
批准号:10729465
-
项目类别:
-
资助金额:$36.05万
-
财政年份:2023
-
负责人:SYLVIA KATINA PLEVRITIS
-
依托单位:
Data Analysis Core
-
批准号:10531082
-
项目类别:
-
资助金额:$43.55万
-
财政年份:2022
-
负责人:SYLVIA KATINA PLEVRITIS
-
依托单位:
Data Analysis Core
-
批准号:10709577
-
项目类别:
-
资助金额:$52.33万
-
财政年份:2022
-
负责人:SYLVIA KATINA PLEVRITIS
-
依托单位:
Stanford Tissue Mapping Center
-
批准号:10213802
-
项目类别:
-
资助金额:$37.23万
-
财政年份:2018
-
负责人:SYLVIA KATINA PLEVRITIS
-
依托单位:
Biomedical Data Science Graduate Training at Stanford
-
批准号:9901621
-
项目类别:
-
资助金额:$30.84万
-
财政年份:2016
-
负责人:SYLVIA KATINA PLEVRITIS
-
依托单位:
Cancer Systems Biology Scholars Program
-
批准号:8607795
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2014
-
负责人:SYLVIA KATINA PLEVRITIS
-
依托单位:
Cancer Systems Biology Scholars Program
-
批准号:9120344
-
项目类别:
-
资助金额:$53.31万
-
财政年份:2014
-
负责人:SYLVIA KATINA PLEVRITIS
-
依托单位:
Cancer Systems Biology Scholars Program
-
批准号:8852578
-
项目类别:
-
资助金额:$53.72万
-
财政年份:2014
-
负责人:SYLVIA KATINA PLEVRITIS
-
依托单位:
Center
-
批准号:8448715
-
项目类别:
-
资助金额:$126.14万
-
财政年份:2013
-
负责人:SYLVIA KATINA PLEVRITIS
-
依托单位:
COMPUTATIONAL ANALYSIS OF DIFFERENTIATION IN CANCER PROGRESSION
-
批准号:8181389
-
项目类别:
-
资助金额:$46.97万
-
财政年份:2010
-
负责人:SYLVIA KATINA PLEVRITIS
-
依托单位:
Center
-
批准号:8181388
-
项目类别:
-
资助金额:$133.26万
-
财政年份:2010
-
负责人:SYLVIA KATINA PLEVRITIS
-
依托单位:
Modeling the Role of Differentiation in Cancer Progression
-
批准号:8068380
-
项目类别:
-
资助金额:$240.57万
-
财政年份:2010
-
负责人:SYLVIA KATINA PLEVRITIS
-
依托单位:
Modeling the Role of Differentiation in Cancer Progression
-
批准号:8628774
-
项目类别:
-
资助金额:$234.73万
-
财政年份:2010
-
负责人:SYLVIA KATINA PLEVRITIS
-
依托单位:
Modeling the Role of Differentiation in Cancer Progression
-
批准号:8115539
-
项目类别:
-
资助金额:$7.0万
-
财政年份:2010
-
负责人:SYLVIA KATINA PLEVRITIS
-
依托单位:
Modeling the Role of Differentiation in Cancer Progression
-
批准号:8240534
-
项目类别:
-
资助金额:$251.27万
-
财政年份:2010
-
负责人:SYLVIA KATINA PLEVRITIS
-
依托单位:
Modeling the Role of Differentiation in Cancer Progression
-
批准号:7879054
-
项目类别:
-
资助金额:$250.49万
-
财政年份:2010
-
负责人:SYLVIA KATINA PLEVRITIS
-
依托单位:
Modeling the Role of Differentiation in Cancer Progression
-
批准号:8448714
-
项目类别:
-
资助金额:$229.66万
-
财政年份:2010
-
负责人:SYLVIA KATINA PLEVRITIS
-
依托单位:
Computational Modeling of Cancer Biology
-
批准号:6887281
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2004
-
负责人:SYLVIA KATINA PLEVRITIS
-
依托单位:
Cost Effectiveness Analysis of Lung Cancer Screening
-
批准号:6947357
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2004
-
负责人:SYLVIA KATINA PLEVRITIS
-
依托单位:
海外基金